McNeil Expands Tylenol Recall As FDA Criticizes Firm's Response To AERs
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare's reaction to signs of potentially contaminated packaging for OTC products including Tylenol raised FDA's ire and is now costing the firm an extensive product recall